424B5The Raise
Damora Therapeutics, Inc. files 424B5
Filed Feb 18, 2022 · 4y ago · Accession 0001564590-22-005716
Plain English
424B5 filed with the SEC.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 424B5
- Filing date
- Feb 18, 2022
- Report date
- —
- Document
- glto-424b5.htm
- Size
- 75 KB